GI
SUPN icon

GAMMA Investing’s Supernus Pharmaceuticals SUPN Stock Holding History

GAMMA Investing’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$139K Buy
3,218
+55
+2% +$2.51K ﹤0.01% 1612
2026
Q2 		$147K Sell
3,163
-122
-4% -$5.86K 0.01% 1516
2026
Q1 		$170K Sell
3,285
-2,547
-44% -$130K 0.01% 1238
2025
Q4 		$290K Sell
5,832
-100
-2% -$4.86K 0.01% 785
2025
Q3 		$283K Buy
5,932
+3,071
+107% +$124K 0.02% 749
2025
Q2 		$90.2K Buy
2,861
+1,541
+117% +$49.4K 0.01% 1528
2025
Q1 		$43.2K Buy
1,320
+267
+25% +$9.46K ﹤0.01% 1891
2024
Q4 		$38.1K Buy
1,053
+245
+30% +$8.63K ﹤0.01% 1866
2024
Q3 		$25.2K Buy
808
+398
+97% +$12.4K ﹤0.01% 1964
2024
Q2 		$11K Sell
410
-26
-6% -$754 ﹤0.01% 2202
2024
Q1 		$14.9K Buy
436
+169
+63% +$5.03K ﹤0.01% 1838
2023
Q4 		$7.39K Buy
+267
New +$7.08K ﹤0.01% 2055

Other funds holding SUPN

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

GAMMA Investing's SUPN Position: Q3 2026 in Review

GAMMA Investing increased its Supernus Pharmaceuticals (SUPN) stake by 1.7% in Q3 2026, buying an estimated $2.51K and bringing the position to 3,218 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

GAMMA Investing first reported a position in SUPN in Q4 2023 and has held it in 12 quarters since. The position peaked at $290K in Q4 2025. 8 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.

  • GAMMA Investing held 3,218 shares of Supernus Pharmaceuticals worth $139K as of Q3 2026.
  • GAMMA Investing bought 55 Supernus Pharmaceuticals shares in Q3 2026, an estimated $2.51K.
  • Supernus Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1612 holding.
  • GAMMA Investing first reported a position in Supernus Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Supernus Pharmaceuticals position peaked at $290K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.